LEXARIA BIOSCIENCE CORP. (LEXXW)

Healthcare · Pharmaceuticals · Price $0.00
Updated: Jun 11, 2026
Gross Profit (TTM)
$368.0K
Trailing 12 Months
Growth Rate
42.06%
Log-Linear Regression (16Q)
Gross Margin
100.00%
Pricing Power
Revenue
$368.0K
Top Line Sales
Operating Income
$-9.5M
After OpEx

📈 Gross Profit History (16 Quarters)

🧮 LEXXW Gross Profit Breakdown

Gross Profit = Revenue - Cost of Revenue
Revenue (Total Sales) $368.0K
Less: Cost of Revenue (COGS) N/A
Equals: Gross Profit $368.0K

Understanding Gross Profit

Gross Profit is Revenue minus Cost of Revenue (also called Cost of Goods Sold or COGS). It measures how much a company earns from selling its products before subtracting operating expenses. For LEXXW, the trailing twelve month gross profit is $368.0K.

Why Gross Profit Matters

Gross margin (Gross Profit / Revenue) is one of the most important indicators of pricing power and competitive advantage. Companies with high and stable gross margins typically have differentiated products, strong brands, or unique capabilities.

LEXXW's gross profit growth rate of 42.06% (based on log-linear regression of 16 quarters) indicates exceptional growth in core profitability.

Gross Margin: The Key Metric

LEXXW's gross margin of 100.00% shows what percentage of each sales dollar remains after paying direct production costs. Gross margins above 60% are excellent and often indicate software, pharmaceuticals, luxury goods, or other high-value products.

Gross Profit vs Other Profitability Metrics

Operating Income: $-9.5M →

Gross Profit minus operating expenses (SG&A, R&D). Shows profitability after all operating costs but before interest and taxes.

Net Income: $-9.5M →

The bottom line after all expenses including interest and taxes. The final measure of accounting profit.

Free Cash Flow: $-8.7M →

Actual cash generated after capital expenditures. Can differ significantly from gross profit due to working capital and capex.

Revenue: $368.0K →

The top line that gross profit is derived from. Gross margin shows what percentage becomes gross profit.

Summary: LEXXW Gross Profit Trend

LEXARIA BIOSCIENCE CORP. (LEXXW) has a gross margin of 100.00%, which Zyberno classifies as excellent for a Healthcare company — above the 60% threshold Zyberno applies to healthcare businesses where IP protection, regulatory moats, and service complexity shape gross margins. Gross profit grew at 42.06% annually — significantly above the 20% threshold Zyberno associates with high-growth businesses. For complete financial analysis, view the full LEXXW stock report on Zyberno.

Frequently Asked Questions

What is LEXXW's current gross profit?

LEXARIA BIOSCIENCE CORP.'s trailing twelve month (TTM) gross profit is $368.0K, growing at 42.06% annually — significantly above the 20% threshold Zyberno associates with high-growth businesses.

Is LEXXW's gross profit growing?

LEXARIA BIOSCIENCE CORP. (LEXXW) has a gross margin of 100.00%, which Zyberno classifies as excellent for a Healthcare company — above the 60% threshold Zyberno applies to healthcare businesses where IP protection, regulatory moats, and service complexity shape gross margins. Gross profit grew at 42.06% annually — significantly above the 20% threshold Zyberno associates with high-growth businesses.

What is LEXXW's gross margin?

LEXARIA BIOSCIENCE CORP. (LEXXW) has a gross margin of 100.00%, which Zyberno classifies as excellent for a Healthcare company — above the 60% threshold Zyberno applies to healthcare businesses where IP protection, regulatory moats, and service complexity shape gross margins. Gross profit grew at 42.06% annually — significantly above the 20% threshold Zyberno associates with high-growth businesses.

What is the difference between gross profit and net income?

Gross profit is Revenue minus Cost of Revenue only. Net income also subtracts operating expenses, interest, and taxes. LEXXW's gross profit is $368.0K versus net income of $-9.5M.

📊 Valuation Trilogy
Three interconnected metrics built on Owner Earnings
💎
Intrinsic Value
DCF Fair Value
🛡️
Margin of Safety
Valuation Gap
🎯
Expected Return
Projected Annual
Click any metric for full methodology and detailed analysis

📊 Full LEXXW Stock Report

See LEXXW's intrinsic value, margin of safety, DCF valuation, and complete financial analysis with 250+ metrics.

💵 LEXXW Free Cash Flow

Compare to Free Cash Flow which subtracts all capital expenditures, not just maintenance CapEx.

💰 LEXXW Owner Earnings

Compare to Buffett's Owner Earnings metric which uses maintenance CapEx instead of total capital expenditures.

📈 LEXXW Earnings Per Share

Analyze EPS trends, P/E ratio, earnings yield, and per-share profitability metrics.

🎯 LEXXW Earnings Surprise (SUE)

See whether LEXXW is beating or missing its own earnings trend — Standardized Unexpected Earnings and post-earnings drift.

📊 LEXXW Revenue

Analyze revenue trends, growth rate, P/S ratio, and top-line sales performance.

💰 LEXXW Net Income

Analyze the bottom-line profit, P/E ratio, and net profit margin trends.

🔶 LEXXW Operating Income

Analyze EBIT, operating margin, and core business profitability before interest and taxes.

💜 LEXXW Gross Profit

Analyze gross margin, pricing power, and profitability before operating expenses.

View Full LEXXW Report Find More Quality Stocks
Scroll to Top